The effect of brimonidine tartrate on retinal blood flow in patients with ocular hypertension

American Journal of Ophthalmology

Volumn 129, Issue 3, 2000, Pages 297-301

  Carlsson, Anthony M ^a   Chauhan, Balwantray C ^b   Lee, A Arlene ^b   Leblanc, Raymond P ^b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRIMONIDINE; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONFOCAL LASER MICROSCOPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOPPLER FLOWMETRY; DOUBLE BLIND PROCEDURE; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETINA BLOOD FLOW;

ADRENERGIC ALPHA-AGONISTS; ANTIHYPERTENSIVE AGENTS; BLOOD FLOW VELOCITY; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INTRAOCULAR PRESSURE; LASER-DOPPLER FLOWMETRY; MALE; MIDDLE AGED; OCULAR HYPERTENSION; OPHTHALMIC SOLUTIONS; QUINOXALINES; REGIONAL BLOOD FLOW; RETINAL VESSELS; VISUAL ACUITY; VISUAL FIELDS;

EID: 0033997951     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(00)00389-5     Document Type: Article

References (33)

1. Toris C.B., Gleason M.L., Camras C.B., Yablonski M.E. Effects of brimonidine on aqueous humor dynamics in human eyes. Arch Ophthalmol. 113:1995;1514-1517.
2. Schuman J.S., Horwitz B., Choplin N.T., et al. A 1-year study of brimonidine twice daily in glaucoma and ocular hypertension. A controlled, randomized, multicenter clinical trial. Chronic Brimonidine Study Group. Arch Ophthalmol. 115:1997;847-852.
3. Derick R.J., Robin A.L., Walters T.R., et al. Brimonidine tartrate a one-month dose response study . Ophthalmology. 104:1997;131-136.
4. Huang A.S., Pollack I.P. Apraclonidine and the treatment of glaucoma. Ophthalmol Clin North Am. 8:1995;303-314.
5. Wilensky J.T. The role of brimonidine in the treatment of open-angle glaucoma. Surv Ophthalmol. 41:(suppl 1):1996;S3-S7.
6. Munk SA, Wiese A, Thompson CD, MacDonald T. Oxidation potential and allergic response of α-2 agonists. Invest Ophthalmol Vis Sci 1996;37(suppl):S832.
7. Walters T.R. Development and use of brimonidine in treating acute and chronic elevations of intraocular pressure a review of safety, efficacy, dose response, and dosing studies . Surv Ophthalmol. 41:(suppl 1):1996;S19-S26.
8. Nordlund J.R., Pasquale L.R., Robin A.L., et al. The cardiovascular, pulmonary, and ocular hypotensive effects of 0.2% brimonidine. Arch Ophthalmol. 113:1995;77-83.
9. Serle J.B. A comparison of the safety and efficacy of twice daily brimonidine 0.2% versus betaxolol 0.25% in subjects with elevated intraocular pressure. The Brimonidine Study Group III. Surv Ophthalmol. 41:(suppl 1):1996;S39-S47.
10. Åman P., Heijl A. Glaucoma Hemifield Test. Automated visual field evaluation. Arch Ophthalmol. 110:1992;812-819.
11. Michelson G., Schmauss B. Two dimensional mapping of the perfusion of the retina and optic nerve head. Br J Ophthalmol. 79:1995;1126-1132.
12. Riva C.E., Harino S., Petrig B.L., Shonat R.D. Laser Doppler flowmetry in the optic nerve. Exp Eye Res. 55:1992;499-506.
13. Bonner R.F., Nossal R. Principles of laser-Doppler flowmetry. Shepherd A.P., Ödberg P.Å. Laser-Doppler blood flowmetry. 1990;17-45 Kluwer Academic Publishers, Boston.
14. Michelson G., Schmauss B., Langhans M.J., Harazny J., Groh M.J. Principle, validity, and reliability of scanning laser Doppler flowmetry. J Glaucoma. 5:1996;99-105.
15. Nicolela M.T., Hnik P., Schulzer M., Drance S.M. Reproducibility of retinal and optic nerve head blood flow measurements with scanning laser Doppler flowmetry. J Glaucoma. 6:1997;157-164.
16. Chauhan B.C. Confocal scanning laser Doppler flowmetry of the retina and optic nerve head. Anderson D.R., Drance S.M. Encounters in glaucoma research 3 how to ascertain progression and outcome . 1996;263-276 Kugler, Amsterdam.
17. Chauhan B.C., Smith F.M. Confocal scanning laser Doppler flowmetry experiments in a model flow system . J Glaucoma. 6:1997;237-245.
18. Faber J.E. In situ analysis of alpha-adrenoceptors on arteriolar and venular smooth muscle in rat skeletal muscle microcirculation. Circ Res. 62:1988;37-50.
19. Faber J.E., Meininger G.A. Selective interaction of alpha-adrenoceptors with myogenic regulation of microvascular smooth muscle. Am J Physiol. 259:1990;H1126-H1133.
20. McGillivray-Anderson K.M., Faber J.E. Effect of reduced blood flow on alpha 1- and alpha 2-adrenoceptor constriction of rat skeletal muscle microvessels. Circ Res. 69:1991;165-173.
21. Orgül S., Meyer P., Cioffi G.A. Physiology of blood flow regulation and mechanisms involved in optic nerve perfusion. J Glaucoma. 4:1995;427-443.
22. Harris A., Ciulla T.A., Chung H.S., Martin B. Regulation of retinal and optic nerve blood flow. Arch Ophthalmol. 116:1998;1491-1495.
23. Forster B.A., Ferrari-Dileo G., Anderson D.R. Adrenergic alpha 1 and alpha 2 binding sites are present in bovine retinal blood vessels. Invest Ophthalmol Vis Sci. 28:1987;1741-1746.
24. Spada C.S., Nieves A.L., Burke J.A., Woodward D.F., Wheeler L.A. Comparative effects of α-2 adrenoreceptor agonists on microvessel caliber in human retinal tissue. Messmerk K., Kubler W. Sixth World Congress for Microcirculation. 1996;511-514 Monduzzi, Bologna.
25. Lachkar Y., Migdal C., Dhanjil S. Effect of brimonidine tartrate on ocular hemodynamic measurements. Arch Ophthalmol. 116:1998;1591-1594.
26. LeBlanc RP. Twelve-month results of an ongoing randomized trial comparing brimonidine tartrate 0.2% and timolol 0.5% given twice daily in patients with glaucoma or ocular hypertension. Brimonidine Study Group 2. Ophthalmology 1998;105:1960-1967.
27. Lietz A., Hendrickson P., Flammer J., Orgul S., Haefliger I.O. Effect of carbogen, oxygen and intraocular pressure on Heidelberg retina flowmeter parameter "flow" measured at the papilla. Ophthalmologica. 212:1998;149-152.
28. 2. Br J Ophthalmol. 81:1997;360-364.
29. Chauhan B.C., Yu D.-Y., Cringle S.J., Carlsson A.M., Su E.-N. Confocal scanning laser ophthalmoscopy and Doppler flowmetry of the rat retina. Invest Ophthalmol Vis Sci. 38:(suppl):1997;S274.
30. Rankin S.J., Walman B.E., Buckley A.R., Drance S.M. Color Doppler imaging and spectral analysis of the optic nerve vasculature in glaucoma. Am J Ophthalmol. 119:1995;685-693.
31. Harris A., Williamson T.H., Martin B., et al. Test/retest reproducibility of color Doppler imaging assessment of blood flow velocity in orbital vessels. J Glaucoma. 1995;281-286.
32. Joos K.M., Pillunat L.E., Knighton R.W., Anderson D.R., Feuer W.J. Reproducibility of laser Doppler flowmetry in the human optic nerve head. J Glaucoma. 6:1997;212-216.
33. Nicolela M.T., Drance S.M., Rankin S.J., Buckley A.R., Walman B.E. Color Doppler imaging in patients with asymmetric glaucoma and unilateral visual field loss. Am J Ophthalmol. 121:1996;502-510.